Carboplatin/paclitaxelFetal growth restriction following in-utero exposure: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1948卷 / 1期

关键词：

D O I：

10.1007/s40278-023-35675-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：118 / 118

相关论文

共 50 条

[21] PropylthiouracilHypothyroidism and ascites following in-utero exposure: 2 case reports
Reactions Weekly, 2022, 1897 (1) : 319 - 319
[22] ImatinibOmphalocele and craniosynostosis following in-utero exposure: 2 case reports
Reactions Weekly, 2019, 1778 (1) : 241 - 241
[23] OfloxacinBirth defects following in-utero exposure: 2 case reports
Reactions Weekly, 2018, 1719 (1) : 173 - 173
[24] Afatinib/osimertinibOligohydramnios, intrauterine growth restriction following in-utero exposure: case report
Reactions Weekly, 2023, 1956 (1) : 24 - 24
[25] AntineoplasticsTeratogenicity following in-utero exposure: 4 case reports
Reactions Weekly, 2017, 1672 (1) : 39 - 39
[26] MethotrexateCraniosynostosis following an in-utero exposure: 4 case reports
Reactions Weekly, 2017, 1633 (1) : 479 - 479
[27] Epirubicin/dexamethasone interactionCardiotoxicity following in-utero exposure: 2 case reports
Reactions Weekly, 2016, 1594 (1) : 92 - 92
[28] TrazodoneWithdrawal symptoms and asphyxia following in-utero exposure: 2 case reports
Reactions Weekly, 2023, 1953 (1) : 373 - 373
[29] IndometacinOligohydramnios and renal failure following in-utero exposure: 2 case reports
Reactions Weekly, 2020, 1790 (1) : 135 - 135
[30] LevetiracetamNeonatal abstinence syndrome following in-utero exposure: 2 case reports
Reactions Weekly, 2023, 1971 (1) : 148 - 148

← 1 2 3 4 5 →